Best General Drug Manufacturer Stocks to Buy Now (2025)Top general drug manufacturer stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best general drug manufacturer stocks to buy now. Learn More.
Industry: Drug Manufacturers - Gene...
A
General Drug Manufacturers is Zen Rated A and is the 2nd ranked industry out of 145 stock market industries
Learn how the Zen Ratings work| Ticker | Company | Price | 1d % | 1w % | 1m % | 3m % | 6m % | 1y % | 3y % | 5y % | 10y % | 52-week High | 52-week Low | % off 52-week High | % off 52-week Low | Beta | Volume | Vol 1d % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GRFS | GRIFOLS SA | $10.74 | -0.19% | 0.56% | 9.72% | 36.56% | 45.26% | 54.02% | 20.18% | -40.77% | -33.19% | $11.14 | $6.19 | 3.59% | 73.51% | 0.75 | 3,940,000 | 239.66% |
| NVS | NOVARTIS AG | $122.09 | 1.74% | 6.31% | 3.79% | 14.52% | 16.51% | 9.62% | 45.48% | 44.28% | 20.25% | $124.83 | $96.06 | 2.19% | 27.10% | 0.35 | 1,212,000 | 11.40% |
| BIIB | BIOGEN INC | $134.94 | 2.71% | 6.07% | 8.71% | 12.05% | 1.49% | -31.26% | -37.67% | -52.02% | -56.15% | $207.59 | $110.04 | 35.00% | 22.63% | 0.76 | 1,169,000 | -21.96% |
| LLY | ELI LILLY & CO | $684.43 | 2.45% | 12.08% | -9.14% | -4.37% | -18.20% | -24.73% | 123.36% | 362.77% | 740.10% | $972.53 | $623.78 | 29.62% | 9.72% | 0.60 | 8,396,000 | 33.06% |
| AMRN | AMARIN CORP PLC | $15.04 | 4.06% | 4.40% | -0.82% | 48.76% | 28.87% | 26.45% | -53.14% | -88.71% | -66.13% | $17.49 | $7.08 | 14.01% | 112.43% | 1.11 | 86,000 | 43.33% |
| AZN | ASTRAZENECA PLC | $78.47 | 0.89% | 7.64% | 12.59% | 16.49% | 5.84% | -6.75% | 18.50% | 40.22% | 135.55% | $87.68 | $61.24 | 10.50% | 28.14% | 0.43 | 5,718,000 | 14.15% |
| GSK | GSK PLC | $39.23 | 0.33% | 4.13% | 4.07% | 4.76% | 7.51% | -4.93% | 12.62% | -23.44% | -28.70% | $44.67 | $31.72 | 12.18% | 23.70% | 0.37 | 2,705,000 | -7.43% |
| GILD | GILEAD SCIENCES INC | $119.02 | -0.55% | -0.87% | 8.54% | 17.97% | 12.47% | 59.23% | 78.78% | 71.18% | 1.67% | $121.83 | $72.89 | 2.31% | 63.30% | 0.43 | 5,461,000 | 10.82% |
| BMY | BRISTOL MYERS SQUIBB CO | $47.81 | 1.32% | 5.42% | 4.33% | 5.74% | -11.00% | -1.36% | -35.01% | -23.86% | -23.68% | $63.33 | $42.96 | 24.51% | 11.29% | 0.34 | 9,410,000 | -6.96% |
| ABBV | ABBVIE INC | $204.68 | 0.98% | 4.36% | 10.89% | 13.77% | 5.32% | 6.87% | 45.26% | 114.52% | 197.95% | $218.66 | $163.81 | 6.39% | 24.95% | 0.39 | 4,630,000 | 30.13% |
| SNY | SANOFI | $49.04 | 1.49% | 5.60% | 3.43% | -2.14% | -7.75% | -7.87% | 13.55% | -3.08% | -5.79% | $60.12 | $44.73 | 18.42% | 9.64% | 0.35 | 2,462,000 | 46.03% |
| JNJ | JOHNSON & JOHNSON | $174.72 | 1.10% | 1.91% | 13.84% | 18.07% | 13.97% | 11.03% | 6.35% | 18.56% | 76.87% | $175.72 | $140.68 | 0.57% | 24.20% | 0.25 | 8,242,000 | 40.19% |
| PFE | PFIZER INC | $25.11 | 0.12% | 2.28% | 2.15% | 11.24% | -1.64% | -12.43% | -49.47% | -34.45% | -29.18% | $30.43 | $20.92 | 17.48% | 20.06% | 0.42 | 32,466,000 | -19.15% |
| SCLX | SCILEX HOLDING CO | $17.37 | 4.09% | 15.01% | 168.65% | 338.83% | 46.12% | -58.34% | -95.00% | N/A | N/A | $46.20 | $3.60 | 62.40% | 382.50% | 0.39 | 540,000 | 21.62% |
| AMGN | AMGEN INC | $290.29 | 2.13% | 2.86% | 1.35% | 9.12% | 1.25% | -8.89% | 18.08% | 22.00% | 74.61% | $339.17 | $253.30 | 14.41% | 14.60% | 0.48 | 1,933,000 | 8.29% |
| OGN | ORGANON & CO | $9.39 | 0.53% | 2.39% | -1.26% | 7.64% | -39.02% | -53.31% | -69.56% | N/A | N/A | $23.10 | $8.01 | 59.35% | 17.23% | 0.80 | 3,579,000 | -3.53% |
| MRK | MERCK & CO INC | $82.76 | 1.75% | 4.36% | 3.30% | 12.58% | 1.10% | -25.68% | -7.05% | -0.65% | 41.03% | $120.30 | $73.31 | 31.21% | 12.89% | 0.31 | 10,218,000 | -7.48% |
| MIRA | MIRA PHARMACEUTICALS INC | $1.47 | 2.04% | 8.70% | -9.64% | 5.63% | 31.58% | -20.21% | N/A | N/A | N/A | $2.70 | $0.73 | 45.56% | 101.37% | 1.73 | 108,000 | -48.57% |
General Drug Manufacturer Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.